Jack Meehan Analyst PerformanceAnalyst at BarclaysJack Meehan is a stock analyst at Barclays focused in the medical sector, covering 17 publicly traded companies. Over the past year, Jack Meehan has issued 2 stock ratings, including and hold recommendations. While full access to Jack Meehan's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Jack Meehan's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings50 Last 9 YearsBuy Recommendations40.00% 20 Buy RatingsCompanies Covered17 Unique Companies Ratings Distribution50RatingsDistribution of strong buy, buy, hold, and sell ratings by Jack Meehan.RatingPercentageCount Strong Buy0.0%0 ratings Buy40.0%20 ratings Hold44.0%22 ratings Sell16.0%8 ratingsOut of 50 total stock ratings issued by Jack Meehan at Barclays, the majority (44.0%) have been Hold recommendations, followed by 40.0% Buy and 16.0% Sell.Best & Worst CallsBest Call000.0%PPDMar 2020Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%HOLXApr 2017Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNYSE58.8% of companies on NYSE10 companiesNASDAQ41.2% of companies on NASDAQ7 companiesJack Meehan, an analyst at Barclays, currently covers 17 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.Coverage FocusSector IconSectorPercentageMedical15 companies88.2%Miscellaneous1 company5.9%Computer and Technology1 company5.9%Jack Meehan of Barclays specializes in stock coverage within the Medical sector, with additional focus on and Computer and Technology companies.Coverage IndustriesIndustryPercentageMED INSTRUMENTS5 companies29.4%MED - BIOMED/GENE3 companies17.6%MEDICAL SERVICES2 companies11.8%MED - OUTP/HM CRE1 company5.9%COMMERCIAL PHYSICAL RESEARCH1 company5.9%MED PRODUCTS1 company5.9%Miscellaneous1 company5.9%ANALYTICAL INSTRUMENTS1 company5.9%INSTRU - SCIENTFC1 company5.9%MEDICAL LABORATORIES1 company5.9% Jack Meehan's Ratings History at Barclays Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export to Excel CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsLHLabcorp2/3/2025Boost Price Target$247.81$271.00Equal Weight$0.0000.00% ROI Stock Forecasts and Research Tools Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
